Can Roche's Tecentriq leapfrog rival meds in lung cancer? Jury's still out
admin 7th December 2017 Uncategorised 0On Thursday, Roche unveiled positive results from its first-line lung-cancer combo trial—but those results raised more questions than they provided answers.
More: Can Roche's Tecentriq leapfrog rival meds in lung cancer? Jury's still out
Source: fierce